Blockade of central cyclooxygenase (COX) pathways enhances the cannabinoid-induced antinociceptive effects on inflammatory temporomandibular joint (TMJ) nociception
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
The present study is the first to investigate the participation of central cyclooxygenase (COX) pathways in modulating the antinociceptive effects of intracisternally administered cannabinoid on nociception induced by inflammation of the temporomandibular joint (TMJ) in freely moving rats. Following intra-articular injection of 5% formalin in the TMJ, nociceptive scratching behavior was recorded for nine successive 5-min intervals in Sprague-Dawley rats. Intracisternal injection of 30 microg of WIN 55,212-2, a synthetic non-subtype-selective CB1/2 agonist, administered 20 min prior to formalin injection significantly reduced the number of scratches and duration of scratching induced by formalin compared with the vehicle-treated group. Antinociceptive effect of WIN 55,212-2 was blocked by intracisternal injection of 10 microg of AM251, a CB1 receptor-selective antagonist, but not by AM630, a CB2 receptor-selective antagonist. A 10 microg dose of WIN 55,212-2 that was ineffective in producing antinociception became effective following intracisternal administration of NS-398, a selective COX-2 inhibitor; indomethacin, a non-selective COX 1/2 inhibitor; acetaminophen, a putative COX-3 inhibitor, but not following pretreatment with the selective COX-1 inhibitor, SC-560. The ED(50) value of WIN 55,212-2 in the NS-398-treated group was significantly lower than that in the vehicle-treated group. Importantly, administration of low doses of COX inhibitors alone did not attenuate nociception. These results indicate that inhibition of central COX pathways, presumably via COX-2 inhibition, reduces inflammatory pain by enhancing the cannabinoid-induced antinociceptive effect. Based on our observations, combined administration of cannabinoids with COX inhibitors may hold a therapeutic promise in the treatment of inflammatory TMJ pain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159 · cited 1×
“Cannabinoid receptors are localized in anatomical regions involved in nociceptive transmission and modulation, such as the dorsal horn of the spinal cord and the periaqueductal gray (Herkenham et al., 1991; Tsou et al., 1998).”
BackgroundImmunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586 · cited 1×
“Cannabinoid receptors are localized in anatomical regions involved in nociceptive transmission and modulation, such as the dorsal horn of the spinal cord and the periaqueductal gray (Herkenham et al., 1991; Tsou et al., 1998).”
BackgroundCB2 cannabinoid receptor-mediated peripheral antinociception
Malan, P. T., Ibrahim, M. M., Deng, H., Liu, Q., Mata, H. P., Vanderah, T., Porreca, F., & Makriyannis, A. (2001) · Pain · doi:10.1016/s0304-3959(01)00321-9 · Cited by 391
Mechanism of Action of Acetaminophen: Is There a Cyclooxygenase 3?
Botting, R. M. (2000) · Clinical Infectious Diseases · doi:10.1086/317520 · Cited by 350 · cited 2×
“However, others have argued that the target of acetaminophen is the COX-3 enzyme that produces prostaglandins in the central nervous system (Botting, 2000; Ayoub et al., 2004; Botting and Ayoub, 2005).”
BackgroundHerzberg, U., Eliav, E., Bennett, G. J., & Kopin, I. J. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13308-5 · Cited by 307 · cited 1×
“Behavioral studies in animals indicate that cannabinoid receptors are involved in the suppression of pain transmission (Sofia et al., 1973; Moss and Johnson, 1980; Herzberg et al., 1997).”
BackgroundAcetaminophen and the Cyclooxygenase-3 Puzzle: Sorting out Facts, Fictions, and Uncertainties
Kis, B., Snipes, J. A., & Busija, D. W. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085431 · Cited by 250
Elmes, S. J. R., Jhaveri, M. D., Smart, D., Kendall, D. A., & Chapman, V. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03690.x · Cited by 160
Smith, F. L., Fujimori, K., Lowe, J., & Welch, S. P. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00583-2 · Cited by 154 · cited 4×
“This is important because pretreatment with naloxone, a broad spectrum opioid receptor antagonist, is reported to antagonize antinociception produced by intraperitoneal administration of D(9)-THC or anandamide (Smith et al., 1998).”
BackgroundInfluentialAyoub, S. S., Botting, R. M., Goorha, S., Colville-Nash, P. R., Willoughby, D. A., & Ballou, L. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404185101 · Cited by 104 · cited 1×
“However, others have argued that the target of acetaminophen is the COX-3 enzyme that produces prostaglandins in the central nervous system (Botting, 2000; Ayoub et al., 2004; Botting and Ayoub, 2005).”
BackgroundCloning of cyclooxygenase-1b (putative COX-3) in mouse
Kis, B., Snipes, J. A., Gaspar, T., Lenzser, G., Tulbert, C. D., & Busija, D. W. (2006) · Inflammation Research · doi:10.1007/s00011-006-0083-z · Cited by 41 · cited 2×
“Kis et al. (2005, 2006) demonstrated that the mouse COX1b (COX-3) encodes a protein that has a completely different amino acid sequence than the known cyclooxygenases and lacks COX activity.”
BackgroundThe antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat
Cox, M. L., & Welch, S. P. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.04.022 · Cited by 35 · cited 1×
“Further, pretreatment with the kappa opioid receptor antagonist, nor-binaltorphimine, attenuates antinociception induced by D9-THC in arthritic rats (Cox and Welch, 2004).”
BackgroundChapman, V. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00125-3 · Cited by 25 · cited 1×
“Electrophysiological studies also have demonstrated that cannabinoid receptor agonists inhibit the activity of nociceptive neurons in the dorsal horn of the lumbar spinal cord (Drew et al., 2000; Chapman, 2001; Kelly and Chapman, 2001).”
Background
Cited by
Graham, G. G., Davies, M. J., Day, R. O., Mohamudally, A., & Scott, K. F. (2013) · Inflammopharmacology · doi:10.1007/s10787-013-0172-x · Cited by 671
Multiple Functions of Endocannabinoid Signaling in the Brain
Katona, I., & Freund, T. F. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150420 · Cited by 630
“, 2009) require the activation of CB1 receptors (Ahn et al., 2007; Telleria-Diaz et al., 2010).”
BackgroundEmerging strategies for exploiting cannabinoid receptor agonists as medicines
Pertwee, R. G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00048.x · Cited by 436
Pertwee, R. G. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0381 · Cited by 347
Petersen, K. K.-S. (2023) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2022-0082 · Cited by 22
“Animal studies document that non-selective NSAIDs and paracetamol increase the activity of the cannabinoid system [15] and that the effect ofNSAIDs and selective COX-2 inhibitors depends on an intact serotonin system [14].”
Metadata
- Authors
- Ahn, D. K., Choi, H. S., Yeo, S. P., Woo, Y. W., Lee, M. K., Yang, G. Y., Jeon, H. J., Park, J. S., & Mokha, S. S.
- Venue
- Pain
- Published
- 2007-11
- Volume
- 132
- Issue
- 1
- Pages
- 23-32
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W1994410805
- Cited by
- 51
- References
- 12
- FWCI
- 2.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.